News
- UK University Hospitals build the NoRCoRP platform
- Scientists tackle vaccine safety, efficacy and access at global R&D forum
- Federal judge enters consent decree against Washington state juice processor
- FDA Warns Firms to Remove Unauthorized E-liquid Products from Market in First Letters Issued to Manufacturers that Did Not Submit Premarket Applications by Deadline
- Family physicians’ crucial role in mental health
- FDA Grants First Conditional Approval Under Expanded Authority to Control Seizures in Dogs with Idiopathic Epilepsy
- Universal health coverage high on the political agenda during the Regional Director’s visit to Georgia
- CBP, FDA Seize Counterfeit, Unauthorized E-Cigarettes
- EMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca
- FDA Releases Artificial Intelligence/Machine Learning Action Plan
- UNICEF, WHO, IFRC and MSF announce the establishment of a global Ebola vaccine stockpile
- WHO urges governments to promote healthy food in public facilities
- FDA Conditionally Approves First Oral Tablet to Treat Lymphoma in Dogs
- Neglected tropical diseases: WHO to formally launch new road map for next decade
- Canadian University initiated COVID-19 Emergency Department Registry
- Research Association conducts clinical trial of Eye Movements Recording Using a Smartphone
- Five million COVID-19 cases reported in WHO's Eastern Mediterranean Region
- FDA Issues Alert Regarding SARS-CoV-2 Viral Mutation to Health Care Providers and Clinical Laboratory Staff
- Large clinical trial will test combination monoclonal antibody therapy for mild/moderate COVID-19
- FDA Statement on Following the Authorized Dosing Schedules for COVID-19 Vaccines
- Extra dose from vials of Comirnaty COVID-19 vaccine
- EMA recommends COVID-19 Vaccine Moderna for authorisation in the EU
- FDA Takes Steps to Provide Clarity on Developing New Drug Products in the Age of Individualized Medicine
- HHS Announces $22 Billion in Funding to Support Expanded Testing, Vaccination Distribution
- US Institute conducts cclinical trial of Safety, Tolerability and Acceptability of Long-Acting Cabotegravir (CAB LA) for the Prevention of HIV Among Adolescent Males
Clinical Research News
Bevorstehende klinische Studien
-
Aperta Biosciences, LLCNoch keine Rekrutierung
-
Hospices Civils de LyonNoch keine RekrutierungHarninkontinenz | Neurogene Blasen | Harnableitung | Beckenmalignität | HarnblasenkarzinomFrankreich
-
Second Affiliated Hospital, Zhejiang University...RekrutierungNormales Gehör | Lärmbelastung | Preferred Loudness LevelChina
-
Qilu Pharmaceutical Co., Ltd.Noch keine RekrutierungKlarzelliges Nierenzellkarzinom | Eierstockkrebs | Andere fortgeschrittene solide TumorenChina
-
University Hospital, AntwerpNoch keine RekrutierungNekrotisierende Enterokolitis des Neugeborenen | Neugeborenen-Sepsis mit spätem BeginnBelgien, Niederlande
-
VA Office of Research and DevelopmentNoch keine RekrutierungMetastasierender nicht-kleinzelliger Lungenkrebs | Cancer-Associated Weight Loss | Elevated Inflammatory MarkersVereinigte Staaten
-
ENTire Medical Ltd.Noch keine RekrutierungHypertrophie | Tonsillektomie | Obstruktion der Atemwege oben | Adenoidektomie-ChirurgieVereinigte Staaten
-
AbbVieNoch keine RekrutierungMittelschwere bis schwere Psoriasis
-
Institute of Hematology & Blood Diseases Hospital...RekrutierungAplastische Anämie | Klonale Hämatopoese | Immunsuppressive TherapieChina
-
Ahmed Nasser Ali MabkhoutRekrutierungKieferzysten | Alveolar Bone DefectsJemen
-
University of CoimbraNoch keine Rekrutierung
-
AbbVieNoch keine Rekrutierung
